TotalMarketCap

Actinium Pharmaceuticals

ATNMNYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$41.188 M

$1.31 -7.09%

Close of 6 Nov 2026

As of 6 Nov 2026, Actinium Pharmaceuticals (ATNM) has a market capitalization of $41.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$90.0K

#3571 by revenue

Earnings

-$33.9M

Loss-making

Shares outstanding

31,441,436

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #346Gain TherapeuticsGANX$42.1M
  2. #347Alterity TherapeuticsATHE$41.5M
  3. #348Actinium PharmaceuticalsATNM$41.2M
  4. #349Serina TherapeuticsSER$41.1M
  5. #350Hyperion DefiHYPD$39.8M

What if Actinium Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$898,078.38

Per share 685,556× higher

Bitcoin $1.53T

$48,593.46

Per share 37,094× higher

Apple $5.02T

$159,527.78

Per share 121,777× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Actinium Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.